Unknown

Dataset Information

0

Response to tozinameran (BNT162b2) booster in twice-vaccinated kidney transplant and maintenance dialysis patients.

ABSTRACT:

SUBMITTER: Ben-Dov IZ 

PROVIDER: S-EPMC8762983 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine.
| S-EPMC8099313 | biostudies-literature
Unknown Impact of tozinameran (BNT162b2) mRNA vaccine on kidney transplant and chronic dialysis patients: 3-5 months follow-up.
| S-EPMC8731189 | biostudies-literature
Unknown SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response.
| S-EPMC8784230 | biostudies-literature
Unknown Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients.
| S-EPMC8055946 | biostudies-literature
Unknown SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
| S-EPMC8425695 | biostudies-literature
Transcriptomics Impaired antigen-specific memory B cell and plasma cell responses including lack of specific IgG upon SARS-CoV-2 BNT162b2 vaccination among Kidney Transplant and Dialysis patients
2021-06-11 | GSE176442 | GEO
Unknown Long-term Antibody Response to the BNT162b2 Vaccine Among Maintenance Hemodialysis Patients.
| S-EPMC8463099 | biostudies-literature
Unknown Recovery of Kidney Function Among Patients With Glomerular Disease Starting Maintenance Dialysis.
| S-EPMC8016208 | biostudies-literature
Unknown Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2.
| S-EPMC8274271 | biostudies-literature
Unknown Metabolomics Evaluation of Patients With Stage 5 Chronic Kidney Disease Before Dialysis, Maintenance Hemodialysis, and Peritoneal Dialysis.
| S-EPMC7855177 | biostudies-literature